Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Neuroone Medical Technologies (NMTC) Return on Sales (2020 - 2026)

Neuroone Medical Technologies filings provide 12 years of Return on Sales readings, the most recent being 0.01% for Q1 2026.

  • On a quarterly basis, Return on Sales rose 1.0% to 0.01% in Q1 2026 year-over-year; TTM through Mar 2026 was 0.01%, a 0.0% change, with the full-year FY2025 number at 0.0%, up 3.0% from a year prior.
  • Return on Sales hit 0.01% in Q1 2026 for Neuroone Medical Technologies, down from 0.0% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.01% in Q4 2024 to a low of 0.86% in Q2 2022.
  • Median Return on Sales over the past 5 years was 0.03% (2023), compared with a mean of 0.15%.
  • Biggest five-year swings in Return on Sales: decreased -12bps in 2022 and later surged 81bps in 2023.
  • Neuroone Medical Technologies' Return on Sales stood at 0.15% in 2022, then skyrocketed by 77bps to 0.03% in 2023, then soared by 116bps to 0.01% in 2024, then crashed by -191bps to 0.0% in 2025, then tumbled by -75bps to 0.01% in 2026.
  • The last three reported values for Return on Sales were 0.01% (Q1 2026), 0.0% (Q4 2025), and 0.01% (Q3 2025) per Business Quant data.